Live Breaking News & Updates on Martina Sersch

Stay updated with breaking news from Martina sersch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gracell Biotechnologies Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients

Gracell also presented data on GC012F for treatment of B-NHL and allogeneic TruUCAR-candidate GC502 for treatment of B-ALLManagement to host clini. ....

Stephanie Carrington , Martina Sersch , Marvin Tang , Kyle Evans , Exchange Commission , Prnewswire Gracell Biotechnologies Inc , Gracell Biotechnologies Inc , Drug Administration , European Hematology Association , Chief Medical Officer , Orphan Drug Designation , Private Securities Litigation Reform Act ,

Gracell Biotechnologies Inc. (GRCL) CEO Dr. William Cao on Q1 2022 Results - Earnings Call Transcript

Gracell Biotechnologies Inc. (NASDAQ:NASDAQ:GRCL) Q1 2022 Earnings Conference Call May 16, 2022 8:00 a.m. ....

San Diego , United States , Kevin Xie , William Cao , Martina Sersch , Joe Catanzaro , Piper Sandler , Kelly Shi , Nick Abbott , Company Participants , Gracell Biotechnologies Inc , Wells Fargo , Gracell Biotechnologies , Conference Call May , Gracell Biotechnologies First Quarter , First Quarter , Update Conference Call , Chief Executive Officer , Chief Medical Officer , Risk Factors ,

Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to. ....

United States , Martina Sersch , Marvin Tang , Kyle Evans , Exchange Commission , Prnewswire Gracell Biotechnologies Inc , Gracell Biotechnologies Inc , European Hematology Association , American Cancer Society , Chief Medical Officer , American Cancer , Private Securities Litigation Reform Act , Gracell Biotechnologies Inc ,

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to. ....

United States , Stephanie Carrington , Martina Sersch , Marvin Tang , Kyle Evans , Prnewswire Gracell Biotechnologies Inc , Gracell Biotechnologies Inc , Orleans Convention Center , Exchange Commission , American Association For Cancer Research , American Cancer Society , American Association , Cancer Research , Annual Meeting , Chief Medical Officer , Phasei Clinical Trials , New Orleans Convention Center , Exhibit Hallsd H , Poster Section , Board Number , Abstract Number , Itinerary Planner , Private Securities Litigation Reform Act , American Cancer ,

Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to. ....

United States , New Orleans , Stephanie Carrington , Martina Sersch , Marvin Tang , William Wei Cao , Kyle Evans , Exchange Commission , Prnewswire Gracell Biotechnologies Inc , American Association For Cancer Research , Gracell Biotechnologies Inc , American Association , Cancer Research , Annual Meeting , Itinerary Planner , Chief Medical Officer , Chief Executive Officer , Private Securities Litigation Reform Act , Acute Lymphoblastic Leukemia , Gracell Biotechnologies Inc ,